The development of an in vivo model of checkpoint acquired resistance, reveals a program of interferon hyperstimulation, resulting in dysregulation of MHC class I, protein translation/trafficking, and other unique pathways, that may be useful for guiding clinical strategy in patients with phenotypic similarities Meeting Abstract


Authors: Fromm, G. J.; Memon, D.; de Silva, S.; Yoo, K. J.; Johannes, K.; Shuptrine, C.; Miriyala, J.; Patel, A.; Rangwala, F.; Opheim, Z.; Nguyen, T. A.; Gonzalez, L.; Rangwala, F.; Schreiber, T. H.; Hellmann, M. D.; Miller, M. L.; Schreiber, T. H.
Abstract Title: The development of an in vivo model of checkpoint acquired resistance, reveals a program of interferon hyperstimulation, resulting in dysregulation of MHC class I, protein translation/trafficking, and other unique pathways, that may be useful for guiding clinical strategy in patients with phenotypic similarities
Meeting Title: 112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 81
Issue: 13 Suppl.
Meeting Dates: 2021 Apr 10-15/May 17-21
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-07-01
Language: English
ACCESSION: WOS:000680263504463
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2021-1697
Notes: Meeting Abstract: 1697 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann